Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL LIABILITIES
Total Liabilities HALO - Halozyme Therapeutics, Inc.
1.7 B
LAST VALUE
0.83%
2 YEAR CAGR
29.09%
5 YEAR CAGR
29.86%
10 YEAR CAGR